B-cell acute lymphoblastic leukemia (B-ALL) is the most common cancer in children, accounting for around 85% of pediatric ...

An international clinical trial shows an innovative CAR-T cell immunotherapy is promising against aggressive T cell cancers and has manageable side effects.

MS patients on B-cell depleting therapies are still protected against COVID-19 risk due to greater anti-viral T-cell activity, a study found.

The findings suggest assessment of CD20 may be an important factor in determining treatment options in B-cell lymphomas.

The US FDA has granted regenerative medicine advanced therapy (RMAT) designation to AbelZeta Pharma’s C-CAR168.

Is it better to take B6 vs. B12? A dietitian explains that both are necessary for supporting your overall health, but there ...

Although the world has largely moved on from Covid-19, a lot of trust was destroyed including – unfortunately and worryingly ...

This designation is meaningful as it signifies our continued commitment to making biosimilars more accessible. Both biosimilars and interchangeable biosimilars are highly similar and have no ...

Talin is a protein that plays an important role in the immune system by activating integrins, receptors that help cells attach to one another. Now a new study by Fox Chase Cancer Center researchers ...

Like many innovative thinkers, molecular biologist Bonnie Bassler began with a question: How do bacteria get any bang for ...

Nervous necrosis virus typically enters host cells via endocytosis, but it can also enter via a process called macropinocytosis.

The brain is a unique place. It is shielded from much of the body by the blood-brain barrier, meaning it's protected from ...